Combination chemotherapy with epirubicin, cisplatin and 5‐fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma
1994
The palliative efficacy of laser therapy with combination chemotherapy (cisplatin, epirubicin and continuous infusion of 5-fluorouracil) was assessed in 34 patients with inoperable gastro-oesophageal cancer. Comparison was made with a group of 30 patients treated previously by laser alone. Twenty patients responded to chemotherapy. There was a significant improvement in dysphagia, as measured by a decreased laser requirement to maintain satisfactory swallowing. In this non-randomized prospective phase II trial, palliation was attained and some responses were long-lasting (median duration of response 8.7 (range 2.3 to more than 29.2) months)
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
9
References
39
Citations
NaN
KQI